Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 251 - 300 out of 99,945

Document Document Title
WO/2017/195505A1
A method for producing a lipid, said method comprising culturing a transformant, in which the expression of a gene encoding at least one of the following proteins (A) to (D) is promoted in a cyanobacterial cell, and thus allowing the tra...  
WO/2017/196880A1
Provided herein are methods of producing a bioproduct by culturing a cell in a multiphase reactor that comprises supercritical CO2, near critical CO2, or liquid CO2.  
WO/2017/195873A1
The present invention relates to a yeast cell of Yarrowia lipolytica, a cell culture product thereof or an extract of the same. The aforesaid yeast cell, cell culture product and extract of the same are characterized by containing L-hydr...  
WO/2017/197206A1
Embodiment disclosed herein concern compositions and methods for altering bacterial fitness. In certain aspects, altering bacterial fitness slows or prevents development of adaptive resistance to antibiotics in bacteria. In certain embod...  
WO/2017/194424A1
The invention relates to a method for enhancing the erythritol and/or erythrulose productivity and/or yield of an erythritol and/or erythrulose-producing yeast strain, such as Yarrowia lipolytica, comprising inhibiting in said yeast stra...  
WO/2017/196790A1
Eukaryotic algae, which play a fundamental role in global CO2 fixation, enhance the performance of the carbon-fixing enzyme RuBisCO by placing it into an organelle called the pyrenoid where the enzyme's activity is enhanced by the carbon...  
WO/2017/196802A1
An algae cultivation system includes generating a translating hydraulic jump wave that travels across a gas-liquid interface of an algae cultivation fluid contained in the algae cultivation system. The translating hydraulic jump wave has...  
WO/2017/196384A1
Algae harvesting and cultivating systems and methods for producing high concentrations of algae product with minimal energy. In an embodiment, a dead-end filtration system and method includes at least one tank and a plurality hollow fibe...  
WO/2017/195888A1
The purpose of the present invention is to provide a method for potentiation of microorganism proliferation capability, a potentiator for microorganism proliferation capability, and the like, with enable stronger potentiation of microorg...  
WO/2017/195870A1
The yeast cell, cell culture product and extract of the same according to the present invention are a cell of at least one kind of yeast selected from the group consisting of Kodamaea ohmeri, Metschnikowia reukaufii, Meyerozyma caribbica...  
WO/2017/194683A1
The subject disclosure features, in one aspect, a method for producing lipids enriched for EPA, comprising modifying a microalga to increase expression of PFA1, and/or PFA3, and culturing the modified microalga under conditions which all...  
WO/2017/193010A1
Host cells are metabolically engineered to consume glucose and glycerol simultaneously, and to divert glucose from catabolic to anabolic pathways without adversely affecting glucose uptake.  
WO/2017/190671A1
Provided is a method for the high expression of a recombinant human serum albumin, characterized in comprising the step of co-expressing: (a) a human serum albumin gene, and (b) one or more rHSA expression promoting factor genes in a yea...  
WO/2017/192966A1
The present disclosure relates to settling devices for separating particles from a bulk fluid with applications in numerous fields. The particle settling devices of the present disclosure may include a stack of truncoconical cones that m...  
WO/2017/190254A1
An apparatus and method for magnetic separation are provided. The apparatus and method can be used to separate magnetically linked targets from unlinked targets in a suspension. The apparatus has a two-dimensional magnetic array that inc...  
WO/2017/191748A1
The purpose of the invention is to provide a novel modified protein L (PpL) that presents bindability to the κ chain of immunoglobulins and has excellent chemical stability to alkali solutions, an affinity separation matrix having the m...  
WO/2017/192925A1
This invention describes a method of using microbial to produce fats, such as fatty acids and their derivatives, or products derived from the fatty acid synthesis cycle, such as hydroxyfatty acids, methyl ketones, and the like.  
WO/2017/192997A1
The instant disclosure relates to methods for converting mammalian definitive endoderm (DE) cells into specific tissue(s) or organ(s) through directed differentiation. In particular, the disclosure relates to formation of gastric fundus ...  
WO/2017/191093A1
The invention relates to a method for coating microorganisms, preferably probiotic microorganisms, and to a powder of said coated microorganisms, obtained using said method, as well as to compositions comprising said powder.  
WO/2017/192743A1
Disclosed herein are methods, platform, antibodies, vaccines, constructs, and kits for generating a modified multispanning membrane polypeptide. In some instances, also disclosed herein are methods, platform, antibodies, vaccines, constr...  
WO/2017/190257A1
By this invention, for the first time, a method for high-efficiency site-specific genetic engineering, utilizing either native or heterologous CRISPR-Cas9 systems, in the anaerobic bacterium Clostridium pasteurianum, is provided. Applica...  
WO/2017/191195A1
There is provided a method of producing at least one unsaturated amino acid from at least one amino acid comprising at least two carbonyl groups, the method comprising (a) contacting a recombinant microbial cell with a medium comprising ...  
WO/2017/193010A8
Host cells are metabolically engineered to consume glucose and glycerol simultaneously, and to divert glucose from catabolic to anabolic pathways without adversely affecting glucose uptake.  
WO/2017/191884A1
The present invention relates to a novel Alcanivorax sp. A28-3 strain. More particularly, the present invention relates to an Alcanivorax sp. A28-3 strain capable of producing neoagarobiose hydrolase which can saccharify neoagarobiose, a...  
WO/2017/190203A1
The present invention relates to a method for analysing microbial growth and capable of correcting optical density readings and calculating kinetic growth parameters of one or more micro-organism cultures. The data analysis obtained make...  
WO/2017/188157A1
Provided is a highly safe and novel agent for regulating the composition ratio of intestinal bacterial flora. The agent for regulating the composition ratio of intestinal bacterial flora according to the present invention, which regulate...  
WO/2017/186327A1
The present invention relates to recombinant Escherichia coli (E. coil) host cells comprising, in relation to wild-type cells, at least one mutation selected from the group consisting of deletion of the gene relA (ΔrelA); amino acid sub...  
WO/2017/189814A1
The present invention describes methods of identifying high-risk populations or individuals who have positive serology for T.gondii. These methods include obtaining a biological sample from a subject; determining the level of T.gondii cy...  
WO/2017/186907A1
The invention relates to the validation of decontamination processes and in particular to new surrogate organisms and mixtures of said microorganisms used for validating the decontamination processes.  
WO/2017/188061A1
The present invention provides: a storage container for cells that accommodates contents in an inner space defined by an inner surface, wherein at least an inner surface area contacted by the contents out of the inner surface includes a ...  
WO/2017/186146A1
A product and preparation method therefor, the product being obtained by further probiotic fermentation after culturing a macro fungus by using a fruit and vegetable culture medium in which no protein component is added.  
WO/2017/188434A1
A modified fibroin including a domain sequence indicated by formula 1: [(A)nmotif-REP]m. The domain sequence has an amino acid sequence having a reduced (A)nmotif content compared to naturally-derived fibroin, said reduction being equiva...  
WO/2017/188430A1
A modified fibroin including a domain sequence indicated by formula 1: [(A) nmotif-REP]m. The modified fibroin has an amino acid sequence having a reduced glycine residue content compared to naturally-derived fibroin, said reduction bein...  
WO/2017/186026A1
Provided is a method for constructing engineered corynebacterium glutamicum bacteria having a high production of L-lysine. The engineered bacteria are constructed by deactivating the NCgl1221 gene of corynebacterium glutamicum, and the n...  
WO/2017/188518A1
The present invention relates to: a Shewanella oneidensis microorganism for synthesizing formic acid; and a method for synthesizing formic acid by using the same. In the present invention, Shewanella oneidensis was first used for synthes...  
WO/2017/187190A1
This invention relates to the delivery of heterologous peptides or proteins such as therapeutic peptides, therapeutic proteins or antigens to mucosal sites using vesicles derived from the outer membrane of commensal bacteria, recombinant...  
WO/2017/188346A1
[Problem] To provide a material for efficiently capturing and collecting specific cells, and a method for capturing and collecting cells by using said material. [Solution] Provided is a material which is used for capturing and collecting...  
WO/2017/190117A1
Processes and compositions are provided for performing magnetibuoyant separations of different biomolecules (e.g., cells, organelles, etc.) in a biological sample, as well as compositions and kits for performing such methods. Composition...  
WO/2017/189421A1
Described are composition and methods relate to reducing the redox imbalance in anaerobically growing yeast with attenuated glycerol production by re-engineering the pathway for Ac-CoA biosynthesis.  
WO/2017/183570A1
This cell culture vessel 1 is provided with a vessel main body 2 and injection/discharge ports 3a, 3b. The inside of the vessel main body 2 is divided into a plurality of tanks 1st, 2nd by a filter member 4. This makes it possible to eas...  
WO/2017/181920A1
Provided is a method for preparing recombinant human granulocyte colony-stimulating factor; the cDNA used is obtained on the basis of a human source sequence modifed according to Escherichia coli codon preference, and has a high level of...  
WO/2017/182403A1
The present invention provides a method for producing lactic acid in a recombinant yeast cell culture using glucose as carbon source comprising a first, seed fermentation stage to produce biomass wherein the yeast is cultivated in a cult...  
WO/2017/185018A1
Disclosed are synthetic bacteria having de novo metabolic pathways for biosynthesis of select compounds. Further disclosed are methods of use to prevent and treat skin disorders and diseases.  
WO/2017/182828A1
The invention provides novel compounds of formula (I) and their pharmaceutically acceptable salts, metabolites, isomers (e.g. stereoisomers) and prodrugs. Such compounds are effective in the treatment of infections caused by Gram-negativ...  
WO/2017/182442A1
The present invention relates to RImA-inactivated filamentous fungal cells secreting a polypeptide of interest and methods of producing a secreted polypeptide of interest in said cells as well as methods of producing said cells.  
WO/2017/184565A1
Provided are nucleic acids that include a promoter, where the promoter is operable in a Bacteroides cell and is operably linked to a heterologous nucleotide sequence of interest. Also provided are nucleic acids that include a promoter (o...  
WO/2017/183793A1
Streptomyces species strain S-8 isolated from turfgrass rhizosphere soil according to the present invention has been confirmed to have excellent root colonization ability, and to inhibit the growth of Rhizoctonia solani, Pythium graminic...  
WO/2017/183665A1
A regulatory T cell activator comprising a substance capable of inhibiting the binding between DNAX Accessory Molecule-1 (DNAM-1) and CD155.  
WO/2017/184227A3
A method of altering a target nucleic acid sequence within a cell is provided including providing the cell with a donor nucleic acid, providing the cell with a single strand annealing protein, and providing the cell with a single strand ...  
WO/2017/184178A1
In an example implementation, a method of cell lysis includes moving cell fluid from a first reservoir through a microfluidic channel toward a second reservoir, activating a lysing element multiple times as a cell from the cell fluid pas...  

Matches 251 - 300 out of 99,945